| Prev Close | 46.32 |
| Open | 45.86 |
| Day Low/High | 45.77 / 46.46 |
| 52 Wk Low/High | 23.07 / 53.38 |
| Volume | 1.10M |
Aflac Incorporated (AFL)
46.38
0.06
0.13
NYSE
| Exchange | NYSE |
| Shares Outstanding | 702.45B |
| Market Cap | 33.06B |
| P/E Ratio | 7.39 |
| Div & Yield | N.A. (N.A) |
Latest News
This Insurer Looks Just Ducky
Well-regarded supplemental health care insurance firm Aflac sports an 'A' for financial strength -- here's how to play it at this great valuation.
A Six-Stock 'What, Me Worry?' Portfolio
These stocks share a number of attributes, from little or no exposure to China to moderate expected volatility.
Insure Your Portfolio With This 'Dividend Aristocrat'
Aflac is a profit-making machine.
Big Pharma and the Sellers of Its Products Now Have a Problem
Who, out there in the health care sector, is safe?
AFLAC: If It Looks Like a Duck and Quacks Like a Bull...
AFL's price action has gotten stronger and stronger since January/February.
Bullish and Bearish Chart Reversals
What stocks have changed direction in the past week.
Turn to Insurers for Some Portfolio Insurance
There are several names that could provide above-average appreciation going forward.
If It Quacks Like a Duck: Next Aflac Rally?
Even if not, the insurance company seems like a safe place to ride out market volatility.
Aflac Not So Ducky; Could Get Whacked Down to $44
A large top formation spanning nearly two years in duration shows a meaningful decline should unfold.
How to Keep It Simple and Cheap
Applying Graham's strategy produces strong portfolio.
Three Stocks to Consider
Qualcomm's core business -- mobile and connective chipsets -- is more fertile than ever
The Impact of the Weak Yen, Part 2
Its impact on U.S. stocks isn't getting enough attention.
This Morning's Market Setup
Where it began. People don't want to think. And the deeper they get into trouble, the less they want to think. But by some sort of instinct, they feel that they ought to and it makes them feel guilty. So they'll bless and follow anyone who gives the...
March Into Merck, Aflac and Nordstrom Shares
Merck, JPMorgan Chase, Aflac and Nordstrom are undervalued and poised to rise, William Smead, portfolio manager for the Smead Value Investor Fund, tells Gregg Greenberg.
